Bahl & Gaynor Inc. lessened its holdings in shares of National HealthCare Co. (NYSEAMERICAN:NHC) by 13.5% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 19,676 shares of the company’s stock after selling 3,071 shares during the quarter. Bahl & Gaynor Inc.’s holdings in National HealthCare were worth $1,483,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of NHC. BlackRock Inc. raised its stake in shares of National HealthCare by 9.9% in the 2nd quarter. BlackRock Inc. now owns 815,732 shares of the company’s stock valued at $57,409,000 after purchasing an additional 73,614 shares during the period. Schwab Charles Investment Management Inc. raised its stake in shares of National HealthCare by 10.9% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 87,059 shares of the company’s stock valued at $6,128,000 after purchasing an additional 8,540 shares during the period. Rhumbline Advisers raised its stake in shares of National HealthCare by 6.7% in the 2nd quarter. Rhumbline Advisers now owns 12,403 shares of the company’s stock valued at $873,000 after purchasing an additional 775 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of National HealthCare by 65.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,025 shares of the company’s stock valued at $143,000 after purchasing an additional 800 shares during the period. Finally, Renaissance Technologies LLC raised its stake in shares of National HealthCare by 5.5% in the 2nd quarter. Renaissance Technologies LLC now owns 559,200 shares of the company’s stock valued at $39,356,000 after purchasing an additional 29,200 shares during the period.
NHC opened at $80.76 on Friday. National HealthCare Co. has a 1 year low of $57.00 and a 1 year high of $84.90.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 1st. Shareholders of record on Monday, December 31st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.48%. The ex-dividend date is Friday, December 28th.
In related news, Director James Paul Abernathy sold 1,877 shares of National HealthCare stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $80.00, for a total value of $150,160.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Robert Michael Ussery sold 5,257 shares of National HealthCare stock in a transaction dated Tuesday, November 13th. The shares were sold at an average price of $81.10, for a total value of $426,342.70. Following the completion of the sale, the chief operating officer now directly owns 136,981 shares in the company, valued at approximately $11,109,159.10. The disclosure for this sale can be found here. Insiders sold a total of 16,508 shares of company stock worth $1,301,211 in the last three months.
National HealthCare Profile
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, and home health care programs. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy services for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
Further Reading: What are trading strategies for the 52-week high/low?
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Co. (NYSEAMERICAN:NHC).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.